Blood News and Research

RSS
Light-to-moderate drinking can be good for your heart

Light-to-moderate drinking can be good for your heart

Patient enrollment completed in vepoloxamer Phase 3 study for treatment of sickle cell disease

Patient enrollment completed in vepoloxamer Phase 3 study for treatment of sickle cell disease

Researchers investigate effect of naturally-derived pigment ASX on hippocampal function

Researchers investigate effect of naturally-derived pigment ASX on hippocampal function

ReCor gets FDA IDE approval to evaluate ReCor Paradise Renal Denervation System in patients with hypertension

ReCor gets FDA IDE approval to evaluate ReCor Paradise Renal Denervation System in patients with hypertension

EPFL researchers develop portable microfluidic diagnostic device to detect different diseases

EPFL researchers develop portable microfluidic diagnostic device to detect different diseases

Differences in patient education level may compromise safety, efficacy of anticoagulants

Differences in patient education level may compromise safety, efficacy of anticoagulants

First European advice on emergency care for acute heart failure patients published

First European advice on emergency care for acute heart failure patients published

Fight cravings and maintain a healthy weight

Fight cravings and maintain a healthy weight

Newly developed intravital microscopy system proves safe for use in humans

Newly developed intravital microscopy system proves safe for use in humans

Masked hypertension linked with increased risks of kidney, heart and vascular damage

Masked hypertension linked with increased risks of kidney, heart and vascular damage

Stenting and surgery equally effective at lowering long-term risk of stroke

Stenting and surgery equally effective at lowering long-term risk of stroke

Berlin researchers use T cells to target mutations in cancer cells

Berlin researchers use T cells to target mutations in cancer cells

Calgary researchers develop new class of nanomedicines to treat autoimmune diseases

Calgary researchers develop new class of nanomedicines to treat autoimmune diseases

Dr. Elliot J. Androphy receives IGNITE grant to develop drug candidate for spinal muscular atrophy

Dr. Elliot J. Androphy receives IGNITE grant to develop drug candidate for spinal muscular atrophy

New molecular delivery system could help ensure delivery of chemotherapy drugs into tumours

New molecular delivery system could help ensure delivery of chemotherapy drugs into tumours

Australian researchers reveal how nutlins pave way for improving future of cancer treatment

Australian researchers reveal how nutlins pave way for improving future of cancer treatment

3-D map of critical protein could lead to new malaria vaccine

3-D map of critical protein could lead to new malaria vaccine

Antibody can give more precise information about Alzheimer's disease than regular radioactive tracers

Antibody can give more precise information about Alzheimer's disease than regular radioactive tracers

Researchers identify new group of powerful Ebola-fighting antibodies

Researchers identify new group of powerful Ebola-fighting antibodies

UGA scientists discover link between genetics and aging process

UGA scientists discover link between genetics and aging process

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.